CFG (CFG)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceDextrose + Citric acid + Sodium dihydrogen phosphate + Sodium citrateDextrose + Citric acid + Sodium dihydrogen phosphate + Sodium citrate
Dosage form: & nbsphemoconvant solution
Composition:

Sodium citrate pentasecylhydrate 31.94 g, glucose monohydrate (dextrose) 25.5 g, sodium dihydrogen phosphate dihydrate 2.51 g, citric acid monohydrate 3.27 g, water for injection up to 1 liter.

Description:Transparent, slightly yellowish liquid or colorless.
Pharmacotherapeutic group:hemoconvant
ATX: & nbsp

V.07.A.C   Aids for blood transfusion

Pharmacodynamics:

The CFG solution provides an anticoagulant effect by binding calcium cations to citrate anions; In addition, the glucose contained in the preparation serves as a food for blood cells, and phosphate supports the blood buffer system.

The hemoconvant solution is mixed with blood in a ratio of 1 volume to 7 blood volumes.

Indications:

Preservation of blood.

Dosing and Administration:

Procurement of blood is carried out in accordance with the "Instruction for the preparation of canned blood" (approved by the M3 RF 09.05.95). Shelf life of canned blood with CFG is 21 days.

Before use, check the integrity of the consumer container and the tightness of the container.

Form release / dosage:A solution of hemoconvant.
Packaging:

For 63 ml of CFG solution in polymeric containers for blood and its components with a volume of 500 ml.

Containers are packed in a secondary polypropylene or high-pressure polyethylene bag with instructions for use, or they put the instruction in a box in an amount equal to the number of containers.

Storage conditions:

Keep out of reach of children, protected from light, at a temperature of 0 to 25 ° C.

Freezing during transportation is allowed.

Shelf life:2 years.
Do not use at the end of the expiration date printed on the package.
Terms of leave from pharmacies:For hospitals
Registration number:P N002307 / 01
Date of registration:03.04.2011
The owner of the registration certificate:FIRM MEDPOLIMER, JSC FIRM MEDPOLIMER, JSC Russia
Manufacturer: & nbsp
Information update date: & nbsp14.01.2016
Illustrated instructions
    Instructions
    Up